UnknownPhase 1NCT04337437

Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Principal Investigator
Rui Chen, M.D
Clinical Pharmacology Research Center of Peking Union Medical College Hospital
Intervention
Genakumab(drug)
Enrollment
40 target
Eligibility
18-50 years · All sexes
Timeline
20192020

Study locations (1)

Collaborators

Peking Union Medical College Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04337437 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials